Pharmasset

New Drug Approvals Make Or Break Biotechnology Stocks

New Drug Approvals Make Or Break Biotechnology Stocks

Seeking Alpha

Gilead's Pharmasset Purchase Could Help Double Market Cap By 2020

Gilead's Pharmasset Purchase Could Help Double Market Cap By 2020

Seeking Alpha

Gilead could have had Pharmasset cheap: founder

Gilead could have had Pharmasset cheap: founder

Reuters

Pharmasset Shows Inhibitex-to-Achillion Drugmakers Up for Grabs: Real M&A

Pharmasset Shows Inhibitex-to-Achillion Drugmakers Up for Grabs: Real M&A

Bloomberg

Gilead to Buy Pharmasset for $11B for Hepatitis C Treatments

Gilead to Buy Pharmasset for $11B for Hepatitis C Treatments

Bloomberg

Healthcare Sector: Noteworthy Insider Buys And Sells

Healthcare Sector: Noteworthy Insider Buys And Sells

Seeking Alpha

Pharmasset Rises After Hepatitis Drug Shows 100% Cure Rate

Pharmasset Rises After Hepatitis Drug Shows 100% Cure Rate

Bloomberg

Inhibitex Soars as Investors See Another Pharmasset in the Making

Inhibitex Soars as Investors See Another Pharmasset in the Making

TheStreet.com

Pharmasset Takes Lead in Race to Develop Hep C Therapy By Pill

Pharmasset Takes Lead in Race to Develop Hep C Therapy By Pill

TheStreet.com

November Catalysts for Biotech and Drug Stocks

November Catalysts for Biotech and Drug Stocks

Minyanville